Add Yahoo as a preferred source to see more of our stories on Google. InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ten years after PCI for restenosis of a drug-eluting ...
Photo Credit: Adapted from Kirtane AJ. ISR: Why the why matters. mechanism of action identification and ISR on IVUS. Presented at: Fellows 2024. Las Vegas, NV. Two “leave-nothing-behind” ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and ...
PHOENIX (May 18, 2023) – The Society for Cardiovascular Angiography & Interventions (SCAI) today release an expert consensus on the management of in-stent restenosis and stent thrombosis. The ...
TCT 1548: From Brink of the Abyss to Miracle: Haemodynamic Support With Impella For Cardiogenic Shock, Cardiac Arrest and TAVI in a Patient With Severe Aortic Stenosis and Severe LV Dysfunction ...
Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...
REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results